MID-VOLUME · HOSP-HEAVY

insulin glulisine Side Effects

insulin glulisine (also sold as Apidra) sits MID-VOLUME #319 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 40.2% mention hospitalization (4,001 reports). Demographics and serious-outcome tables follow.

Data updated 2026-05-15

9,944
FAERS reports

FDA Adverse Event Reporting System extract for insulin glulisine. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.

insulin glulisine: 40.2% mention hospitalization (4,001 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #319 of 524 by FAERS report count.

Mid-book FAERS page for insulin glulisine (Apidra) (9,944 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.

Counts from the openFDA FAERS extract (2005–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.

BLOOD GLUCOSE INCREASED leads 1,526 of 9,944 reports

BLOOD GLUCOSE INCREASED
1,526
HYPOGLYCAEMIA
756
HYPERGLYCAEMIA
634
BLOOD GLUCOSE DECREASED
445
DIZZINESS
401
MALAISE
392
DYSPNOEA
383
NAUSEA
370
VOMITING
335
ACUTE KIDNEY INJURY
304
FATIGUE
297
ASTHENIA
293
DIARRHOEA
279
PAIN
271
FALL
269
BLOOD GLUCOSE ABNORMAL
267
DIABETES MELLITUS INADEQUATE CONTROL
264
HEADACHE
259
GLYCOSYLATED HAEMOGLOBIN INCREASED
253

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 4,904 (53%)
Male 4,360 (47%)
Unknown 40

Age peak 45-64 (2,851 reports)

0-17 211 (3%)
18-44 970 (13%)
45-64 2,851 (39%)
65-74 1,861 (26%)
75+ 1,372 (19%)

FAERS filings rising toward 2025

2005 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (795 reports, 8.0%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 207
RENAL FAILURE 78
GASTROINTESTINAL HAEMORRHAGE 56
PNEUMONIA 49
BALANCE DISORDER 48
BLOOD GLUCOSE FLUCTUATION 48
COGNITIVE DISORDER 48
CONTRAINDICATED PRODUCT ADMINISTERED 47
HAEMATOMA 47
URINARY INCONTINENCE 47
DIZZINESS 45
ACUTE KIDNEY INJURY 44
CARDIO-RESPIRATORY ARREST 44
DYSPNOEA 39
HYPERHIDROSIS 39
CONFUSIONAL STATE 38
DRUG INTERACTION 36
BLOOD GLUCOSE ABNORMAL 34
FALL 34
RESPIRATORY FAILURE 34

Reactions in Hospitalization Reports

Hospitalization is HEAVY (4,001, 40.2% of the book). Top reactions in those rows:

Reaction Reports
BLOOD GLUCOSE INCREASED 359
HYPOGLYCAEMIA 335
HYPERGLYCAEMIA 330
DYSPNOEA 246
ACUTE KIDNEY INJURY 225
VOMITING 218
DIABETIC KETOACIDOSIS 192
PNEUMONIA 170
MALAISE 162
ASTHENIA 160
ANAEMIA 157
NAUSEA 153
FALL 152
DIARRHOEA 148
GENERAL PHYSICAL HEALTH DETERIORATION 144
DIZZINESS 139
FATIGUE 138
PYREXIA 138
HYPOTENSION 117
How to read insulin glulisine FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)

FAERS holds 9,944 voluntary reports linked to insulin glulisine (Apidra), 2005-2025. Death is listed on 795 (8.0%). Hospitalization appears on 4,001 (40.2%). Top co-reported indication: Diabetes Mellitus.

Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 40.2% mention hospitalization (4,001 reports).

Read with insulin glulisine

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.